Cargando…

Estimating the prevalence of comorbid conditions and their effect on health care costs in patients with diabetes mellitus in Switzerland

BACKGROUND: Estimating the prevalence of comorbidities and their associated costs in patients with diabetes is fundamental to optimizing health care management. This study assesses the prevalence and health care costs of comorbid conditions among patients with diabetes compared with patients without...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huber, Carola A, Diem, Peter, Schwenkglenks, Matthias, Rapold, Roland, Reich, Oliver
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199853/ https://www.ncbi.nlm.nih.gov/pubmed/25336981 http://dx.doi.org/10.2147/DMSO.S69520

Ejemplares similares

Epidemiology and costs of diabetes mellitus in Switzerland: an analysis of health care claims data, 2006 and 2011
por: Huber, Carola A, et al.
Publicado: (2014)

Identifying patients with chronic conditions using pharmacy data in Switzerland: an updated mapping approach to the classification of medications
por: Huber, Carola A, et al.
Publicado: (2013)

Epidemiology and costs of multiple sclerosis in Switzerland: an analysis of health-care claims data, 2011–2015
por: Blozik, Eva, et al.
Publicado: (2017)

One-year adherence to oral antihyperglycemic medication and risk prediction of patient outcomes for adults with diabetes mellitus: An observational study
por: Huber, Carola A., et al.
Publicado: (2016)

An empirical investigation of the efficiency effects of integrated care models in Switzerland
por: Reich, Oliver, et al.
Publicado: (2012)

Prescription of potentially inappropriate medication in older persons in Switzerland: does the dispensing channel make a difference?
por: Blozik, Eva, et al.
Publicado: (2015)

Injections frequency and health care costs in patients treated with aflibercept compared to ranibizumab: new real-life evidence from Switzerland
por: Reich, Oliver, et al.
Publicado: (2017)

Evidence-based quality indicators for primary healthcare in association with the risk of hospitalisation: a population-based cohort study in Switzerland
por: Huber, Carola A, et al.
Publicado: (2020)

A set of four simple performance measures reflecting adherence to guidelines predicts hospitalization: a claims-based cohort study of patients with diabetes
por: Huber, Carola A, et al.
Publicado: (2016)

Medication adherence in patients with diabetes mellitus: does physician drug dispensing enhance quality of care? Evidence from a large health claims database in Switzerland
por: Huber, Carola A, et al.
Publicado: (2016)

Evidence-based indicators for the measurement of quality of primary care using health insurance claims data in Switzerland: results of a pragmatic consensus process
por: Blozik, Eva, et al.
Publicado: (2018)

Estimating healthcare costs of acute gastroenteritis and human campylobacteriosis in Switzerland
por: SCHMUTZ, C., et al.
Publicado: (2017)

Effects of Integrated Care on Disease-Related Hospitalisation and Healthcare Costs in Patients with Diabetes, Cardiovascular Diseases and Respiratory Illnesses: A Propensity-Matched Cohort Study in Switzerland
por: Huber, Carola A., et al.
Publicado: (2016)

Anti-VEGF treatment patterns and associated health care costs in Switzerland: findings using real-world claims data
por: Reich, Oliver, et al.
Publicado: (2015)

The relationship between functional health literacy and the use of the health system by diabetics in Switzerland
por: Franzen, Jasmin, et al.
Publicado: (2014)

Potentially Inappropriate Medication Use in Older Patients in Swiss Managed Care Plans: Prevalence, Determinants and Association with Hospitalization
por: Reich, Oliver, et al.
Publicado: (2014)

Cost–utility analysis of risk-reducing strategies to prevent breast and ovarian cancer in BRCA-mutation carriers in Switzerland
por: Bommer, Claudine, et al.
Publicado: (2021)

The provision of out-of-hours care and associated costs in an urban area of Switzerland: a cost description study
por: Eichler, Klaus, et al.
Publicado: (2010)

Cost-effectiveness and budget impact of venetoclax in combination with rituximab in relapsed/refractory chronic lymphocytic leukemia in Switzerland
por: Barbier, Michaela, et al.
Publicado: (2021)

Prevalence of chronic medical conditions in Switzerland: exploring estimates validity by comparing complementary data sources
por: Zellweger, Ueli, et al.
Publicado: (2014)

Cost-effectiveness of voretigene neparvovec in the treatment of patients with inherited retinal disease with RPE65 mutation in Switzerland
por: Bhadhuri, Arjun, et al.
Publicado: (2022)

Antidepressant prescription practice and related factors in Switzerland: a cross-sectional analysis of health claims data
por: Haller, Elisa, et al.
Publicado: (2019)

Herpes zoster vaccine: A health economic evaluation for Switzerland
por: Blank, Patricia R., et al.
Publicado: (2017)

Small Area Variation of Adherence to Clinical Recommendations: An Example from Switzerland
por: Gruebner, Oliver, et al.
Publicado: (2022)

Benzodiazepine and Z-Drug Use in Switzerland: Prevalence, Prescription Patterns and Association with Adverse Healthcare Outcomes
por: Landolt, Salome, et al.
Publicado: (2021)

Death at no cost? Persons with no health insurance claims in the last year of life in Switzerland
por: Panczak, Radoslaw, et al.
Publicado: (2018)

Outcomes and costs of Ranibizumab and Aflibercept treatment in a health-service research context
por: Schmid, Martin K., et al.
Publicado: (2018)

An estimation of the prevalence of diabetes mellitus and diabetic retinopathy in adults in Timor-Leste
por: Dawkins, Rosie Claire Hewitt, et al.
Publicado: (2015)

Cost Effectiveness and Budget Impact of Siponimod Compared to Interferon Beta-1a in the Treatment of Adult Patients with Secondary Progressive Multiple Sclerosis with Active Disease in Switzerland
por: Schur, Nadine, et al.
Publicado: (2021)

General Practitioners’ Awareness and Perception of Current Pneumococcal Vaccination for Adult Patients with Known Risk Factors in Switzerland: Evidence from a Survey
por: Stoffel, Sandro Tiziano, et al.
Publicado: (2023)

The prevalence of restless legs syndrome and comorbid condition among patient with type 2 diabetic mellitus visiting primary healthcare
por: Bener, Abdulbari, et al.
Publicado: (2019)

Variation of colorectal, breast and prostate cancer screening activity in Switzerland: Influence of insurance, policy and guidelines
por: Ulyte, Agne, et al.
Publicado: (2020)

Estimating the indirect prevalence of female genital mutilation/cutting in Switzerland
por: Cottler-Casanova, S., et al.
Publicado: (2021)

Explainable artificial intelligence on life satisfaction, diabetes mellitus and its comorbid condition
por: Kim, Ranyeong, et al.
Publicado: (2023)

Multimorbidity, health care utilization and costs in an elderly community-dwelling population: a claims data based observational study
por: Bähler, Caroline, et al.
Publicado: (2015)

Prevalence and associated factors of tuberculosis and diabetes mellitus comorbidity: A systematic review
por: Workneh, Mahteme Haile, et al.
Publicado: (2017)

Variation of preoperative chest radiography utilization in Switzerland and its influencing factors: a multilevel study with claims data
por: Wei, Wenjia, et al.
Publicado: (2018)

Health Care and Productivity Costs Associated With Diabetic Patients With Macrovascular Comorbid Conditions
por: Fu, Alex Z., et al.
Publicado: (2009)

Routine Data Sources Challenge International Diabetes Federation Extrapolations of National Diabetes Prevalence in Switzerland
por: Bopp, Matthias, et al.
Publicado: (2011)

Cost-Effectiveness Analysis of Sofosbuvir Compared to Current Standard Treatment in Swiss Patients with Chronic Hepatitis C
por: Pfeil, Alena M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jr7bt5a8vlds5ds9ino2lqa6ns